Loading clinical trials...

Panitumumab IRDye800 Optical Imaging Study | Clinical Trials | Clareo Health

COMPLETEDPhase 1NCT02415881

Panitumumab IRDye800 Optical Imaging Study

Phase I trial to evaluate the safety of escalating dose levels of conjugated panitumumab-IRDye800 in subjects with head and neck squamous cell carcinoma (HNSCC) that undergo surgery with curative inte...

Lead sponsor: Eben Rosenthal•2 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 1

MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors

NCT05076760 · Solid Tumor, Advanced Cancer, and more

RECRUITINGPhase 2/3

Trop2-targeted immunoPET Imaging of Solid Tumors

NCT06851663 · Solid Tumor, Solid Carcinoma, and more

RECRUITING

DESTINY-PANTUMOUR04

NCT07124000 · Adenocarcinoma (NOS), Anal Cancer, and more

RECRUITINGPhase 2

Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)

NCT07209189 · Head and Neck Cancer, Squamous Cell Carcinoma, and more

RECRUITINGPhase 2

Invert-Prospective Phase II Randomized Trial of Involved Nodal Versus Elective Neck RadioTherapy

NCT06477692 · Head and Neck Cancer

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 24, 2021Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment64

Start dateAug 2016

Last updatedSep 24, 2021

Condition

Head and Neck Cancer

Locations shown

University of Alabama at Birmingham Cancer Center

Birmingham, Alabama

Stanford University, School of Medicine

Stanford, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 24, 2021Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions